Hubei Sinophorus Electronic Materials (688545.SH) plans to jointly establish Hubei Xingfa Investment Co., Ltd.
Xingfu Electronics (688545.SH) announced that the company intends to co-invest with Hubei Xingfa and Yichang Xingfa to establish a joint venture named Hubei Xingfa Investment Co., Ltd. The registered capital of Xingfa Investment is set at 150 million yuan, with Hubei Xingfa planning to contribute 76.5 million yuan, accounting for 51%; Yichang Xingfa intending to contribute 36.75 million yuan, accounting for 24.5%; and the company planning to invest 36.75 million yuan of its own funds, also accounting for 24.5%. The purpose of this external investment is to build a specialized industrial investment platform, integrating various industrial resources, project channels, and capital advantages, and to conduct equity investment and industrial investment along the upstream and downstream of the industrial chain.
Hubei Sinophorus Electronic Materials (688545.SH) announced that the company plans to jointly invest with Hubei Xingfa and Yichang Xingfa to establish a joint venture called Hubei Xingfa Investment Co., Ltd. The registered capital of Xingfa Investment is 150 million yuan, of which Hubei Xingfa plans to invest 76.5 million yuan, accounting for 51%; Yichang Xingfa plans to invest 36.75 million yuan, accounting for 24.5%; and the company plans to invest 36.75 million yuan with its own funds, also accounting for 24.5%. The purpose of this external investment is to build a specialized industrial investment platform to integrate various industrial resources, project channels, and capital advantages, focusing on equity investment and industrial investment along the upstream and downstream of the industrial chain.
Related Articles
Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares, at a price of approximately HK$72.88 per share.
JPMorgan Chase & Co. reduced its holdings in FLAT GLASS (06865) by approximately 1,145,500 shares, at a price of about HKD 7.61 per share.
JPMorgan reduced its holdings in Chifeng Jilong Gold Mining (06693) by approximately 145,100 shares, with each share priced at about HKD 33.05.
Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares, at a price of approximately HK$72.88 per share.
JPMorgan Chase & Co. reduced its holdings in FLAT GLASS (06865) by approximately 1,145,500 shares, at a price of about HKD 7.61 per share.
JPMorgan reduced its holdings in Chifeng Jilong Gold Mining (06693) by approximately 145,100 shares, with each share priced at about HKD 33.05.
RECOMMEND
